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The rabbitpox virus (RPV) B5R protein, synthesized late in infection, is found as a 45-kDa membrane-associated protein
of the envelope of infectious extracellular enveloped virus (EEV) and as a 38-kDa protein secreted from the cell by a process
independent of morphogenesis. The protein is not found associated with intracellular mature virus (IMV). Deletion of the
gene attenuates the virus (RPVDB5R) in animals (mice and rabbits), has relatively little effect on formation of IMV, prevents
EEV formation in some but not all cells, and leads to a reduced host range. Analysis of the sequence of the protein suggests
relatedness to factor H of the complement cascade. Collectively, these observations suggest that attenuation of the virus
in vivo could be linked to an inhibition of the inflammatory response, a deficiency in growth, or both. In this report we have
analyzed the behavior of RPVDB5R in infected mice and rabbits and conclude that attenuation of the mutant virus likely
results from simple failure to grow within the infected animal and that the inflammatory response probably contributes little
to the observed attenuation. q 1997 Academic Press
that endow these viruses with the ability to replicate inINTRODUCTION
a wide variety of cell types.
In recent years, it has come to be appreciated that theThe poxviruses comprise an extensive family of large,
poxviruses also produce several proteins which, in vitro,cytoplasmic DNA viruses capable of infecting a broad
are capable of interacting with and neutralizing criticalrange of animal species. Several of these viruses are
components of the host immune system. Indeed, in someknown to cause a severe and often fatal illness in certain
cases, it has been demonstrated that expression of thesehosts. One dramatic example is variola major, an ortho-
viral proteins is important for full viral virulence. Manypoxvirus which is the causative agent of smallpox in man.
of these viral-encoded proteins either share sequenceA second member of the orthopoxvirus genus is rabbit
homology and/or react directly with regulatory compo-poxvirus (RPV), which was originally isolated at the
nents of the host immune system. Examples of such viral-Rockefeller Institute in 1934, during a spontaneous, lethal
encoded homologues include a secreted interleukin-1boutbreak of infection in rabbits. RPV in rabbits is similar
receptor (Alcami and Smith, 1992; Spriggs et al., 1992), anto variola in virulence, in that infection of the host animal
interferon-g receptor (Alcami and Smith, 1995; Seregin etrapidly leads to a generalized, disseminated infection
al., 1996; Mossman et al., 1995b, 1995a), TNF receptorwhich results in death in the majority of cases (Bedson
(Smith et al., 1991; Hu et al., 1994; Schreiber and McFad-and Duckworth, 1963). The production of a lethal infec-
den, 1994), a complement C4b-binding protein (Kotwaltion, combined with the availability of an animal model,
et al., 1990; Kotwal and Moss, 1988), and a serine protein-makes RPV an attractive candidate for studying the ef-
ase inhibitor, designated as SPI-2 or crmA (Palumbo etfects of specific genes on poxvirus virulence.
al., 1989; Pickup et al., 1986).In the laboratory, the infection of rabbits with RPV is
Interest in the crmA gene was heightened when it wasinitiated by intradermal inoculation. In order to develop
shown that inactivation of the gene in cowpox virus (CPV)the subsequent lethal infection, the virus must initially
resulted in the production of white, inflammatory pocksreplicate within a variety of cell types at the localized
on the chorioallantoic membrane (CAM) of embryonatedsite of inoculation. Then, the virus must efficiently spread
chicken eggs, instead of the red, hemorrhagic, nonin-to secondary sites (tissues and organs) and continue
flammatory pocks typical of wild-type CPV (Pickup et al.,replication as the host attempts to mount a defensive
1986). Subsequently, it was shown that the crmA proteinresponse. It has been known for quite some time that
is a powerful inhibitor of the interleukin-1b convertasemany poxviruses possess a variety of ancillary genes
(ICE), a key enzyme in the production of the proinflamma-
tory cytokine, interleukin-1b (IL-1b) (Ray et al., 1992).
The evaluation of pock color on the CAM is a well-1 To whom reprint requests should be addressed.
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established system which has proven invaluable for the with the result that the virus fails to plaque on this cell
line (Martinez Pomares et al., 1993). Similar results instudy of the immune modulating effects of the crmA pro-
tein. RPV, like CPV, also produces red, hemorrhagic other cell lines have been reported for B5R mutants of
vaccinia, where mutations in the B5R gene inhibit extra-pocks on the CAM and mutants of the RPV crmA gene
likewise produce white, inflammatory lesions. Those le- cellular virus production (Engelstad and Smith, 1993;
Wolffe et al., 1993). In addition, we showed that mutationssions, like those of CPVDcrmA(SPI-2), are impacted with
heterophils (Fredrickson et al., 1992; Palumbo et al., 1989; in the B5R gene resulted in the production of nonhemor-
rhagic, white-pocks on the CAM, similar in appearanceR. J. Stern and R. W. Moyer, unpublished results). The
heterophilia and resultant white pock phenotype are pre- to those produced by crmA mutants of CPV or RPV (Marti-
nez Pomares et al., 1993). This information, combinedsumed to result directly from the inability of the mutant
virus to block the host inflammatory response as demon- with the homology to Factor H, suggested a possible
role for the B5R protein in the regulation of the hoststrated by the phenotypic reversion of this white-pock
phenotype back to red pocks when infections of the CAM inflammatory response. Since it was suspected that viral
suppression of the host inflammatory response is im-are done in the presence of anti-inflammatory agents
such as dexamethasone (Fredrickson et al., 1992). portant in allowing full manifestation of viral virulence,
we suggested that the observed attenuation of virus inThe B5R protein homolog encoded by RPV is virtually
identical to that encoded by the B5R gene of vaccinia animals resulting from deletion of the B5R gene might
well be related to an enhanced inflammatory responsevirus. The B5R protein is yet another poxvirus protein
that shares sequence homology with a component of the in accordance with what was believed to be the explana-
tion for white pocks on the CAM.immune system (Factor H) (Takahashi Nishimaki et al.,
1991; Engelstad et al., 1992). The 45-kDa glycoprotein In this paper, we extend our previous results and show
that mutations in the B5R protein of RPV result in majorencoded by this gene is produced late during the viral
infection and is found as a component of extracellular attenuation of RPV virulence in rabbits as well as mice.
The attenuation could, however, be a manifestation ofenveloped virus particles (EEV) released from the cell
(Isaacs et al., 1992; Wolffe et al., 1993; Engelstad et al., poor growth in the animal, related to a failure to contain
the inflammatory response of the host or both. In the1992; Engelstad and Smith, 1993; Takahashi Nishimaki
et al., 1991; Martinez-Pomares et al., 1995). The B5R pro- studies presented here, we attempt to resolve these pos-
sibilities and specifically address the possible involve-tein is not found in intracellular mature virus (IMV) (Isaacs
et al., 1992; Wolffe et al., 1993; Engelstad and Smith, ment of the host inflammatory response on RPV B5R
mutant infections in both the CAM and animal systems.1993; Martinez Pomares et al., 1993), an infectious form
of the virus which is further processed to form EEV. In We conclude that attenuation results most likely from an
impaired ability of the B5R mutant virus to grow effec-addition, the B5R protein is found in the supernatant of
infected cells as a smaller, secreted 38-kDa protein de- tively in animal hosts.
rived by cleavage of the 45-kDa form, a process which
is believed to occur on the cell surface independent of MATERIALS AND METHODS
EEV formation (Martinez Pomares et al., 1993).
Cells, viruses, and eggs
Examination of the amino acid sequence of the B5R
protein reveals four short, conserved repeat (SCR) re- RPV Utrecht strain was obtained from the American
Tissue Type Culture collection. CPV Brighton Red straingions of approximately 60 amino acids each, flanked by
cysteine residues (Engelstad and Smith, 1993; Takahashi was a generous gift from Dr. David Pickup (Duke Univer-
sity). All virus stocks were grown on RK-13 cells (ATCC).Nishimaki et al., 1991). These SCR regions are typically
found in members of a protein family involved in the Virus used for animal infections was purified as follows:
Infected cells were harvested, lysed by dounce homoge-regulation of the complement system (Hourcade et al.,
1989). Comparison of the amino acid sequence with the nization, and spun at 500 g to remove nuclei. The super-
natants were then layered onto 36% sucrose and spunprotein databases using the BLAST program (National
Center for Biotechnology Information (NCBI), Bethesda, at 65,000 g for 90 min. Viral pellets were resuspended
in PBS and stored at0707C. Plaque assays were done onMD), revealed that the B5R protein shares regions of
homology with Factor H, a regulatory component of the RK-13 cells except where mycophenolic acid selection of
recombinant virus was performed, in which case, assayscomplement cascade. Factor H is a component of the
alternative pathway of the complement cascade which were performed on CV-1 cells (ATCC).
RK-13 and CV-1 cells were cultured in Gibco minimalacts to destabilize the formation of C3b complex and
can therefore be viewed as a negative regulator of the essential medium (MEM) containing streptomycin (50 IU/
ml), penicillin (50 mcg/ml), glutamine (2 mM), sodiumcomplement system.
In previous work, we have shown that interruption of pyruvate (1 mM), MEM nonessential amino acids (0.1
mM), and 5% fetal bovine serum (GIBCO). Chicken em-the RPV B5R open reading frame leads to low production
of IMV and virtually no EEV in chick embryo fibroblasts, bryo fibroblasts were prepared and maintained for eight
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passages in medium 199 (Gibco) with 5% fetal bovine
serum.
Embryonated White Leghorn chicken eggs were ob-
tained from SPAFAS, Inc. (Roanoke, IL) and incubated at
37.57C in a Kuhl incubator (Flemington, NJ) according to
the manufacturers instructions. At 11 days postfertiliza-
tion, the CAM was inoculated with virus suspended in
100ml of sterile PBS. In CAM experiments involving dexa-
methasone, the virus was resuspended in PBS con-
taining 8 mM dexamethasone (Sigma Chemical Co.),
streptomycin (50 IU/ml), and penicillin (50 mcg/liter)
(Fredrickson et al., 1992). The infected eggs were incu- FIG. 1. Rectal temperatures of intradermally infected rabbits. Rabbits
bated for an additional 72 hr after which, the CAMs were were infected intradermally with either 500 PFU (s, h) or 50000 PFU
(j, l) of wtRPV (A) or RPVDB5R (B). Temperatures were recordedremoved for examination. Staining of CAMs with NBT
every 24 hr following infection. D, died; E, euthanized.(Fredrickson et al., 1992) was accomplished by incuba-
tion of PBS rinsed membranes for 30 min at 377C in PBS
containing 0.1% nitro-blue tetrazolium (Kodak). where (Martinez Pomares et al., 1993). Briefly, the open
reading frame for the Escherichia coli guanyl-ribosylpho-
Animals and animal infections sphotransferase (gpt) gene under the control of the pox-
viral p7.5 promoter was cloned into a unique EcoRV re-Adult (approximately 3 kg) female rabbits were ob-
striction site within the cloned RPV B5R gene. A plasmidtained from M & P’s rabbitry (Tampa, FL) and were
containing this interrupted gene was then used to con-housed in individual cages. To initiate the infection in
struct an RPVDB5R mutant following transfection of thisthese animals, virus, resuspended in 100 ml of PBS, was
plasmid into wtRPV-infected cells followed by selectioninjected intradermally into the shaved flank of each ani-
of the recombinant virus based on resistance to myco-mal. Rectal temperatures were recorded using a digital
phenolic acid (MPA).thermometer (Becton –Dickinson, Franklin, NJ).
Six- to 8-week-old (15– 20 g) female Balb/c mice were
RESULTSobtained from either Harlan – Sprague– Dawley Inc. (Indi-
anapolis, IN) or the Jackson Laboratories (Bar Harbor, Attenuation of RPVDB5R in rabbits
ME). Intranasal infections of mice were performed as
In order to expand our knowledge of the effects offollows: Mice were first anesthetized by intraperitoneal
eliminating the RPV B5R gene on virulence, we comparedinjection of 100 ml of sodium pentobarbital (0.05– 0.1 mg/
the ability of wtRPV and RPVDB5R to cause disease ing body weight) following which the mice were inoculated,
rabbits. Rabbits may be considered a ‘‘more natural host’’10 ml per nostril, with virus diluted in PBS, using a micro-
for RPV and are exquisitely sensitive to infection. A lethalcapillary pipet. In experiments involving the use of dexa-
infection can frequently be initiated by intradermal inocu-methasone, mice were given twice-daily intraperitoneal
lation of a single plaque forming unit (PFU) of RPV. Theinjections of 100 ml of sterile PBS containing dexametha-
progress of the infection in these animals can easily besone-21 phosphate (Sigma) (500 mg/ml). Ear swelling
followed by monitoring the increase in body temperaturewas induced in mice by the application to one ear of 25
as well as by noting the secondary signs of infectionml of croton oil (5% in ethanol) (Sigma). Ear thickness
which develop such as nasal discharge, dyspnea, andwas measured using an engineers micrometer (Starret,
secondary/satellite lesions which are indicative of vire-Athol, MA) (Trottier and Ogolla, 1990).
mia. The data of Fig. 1 compares the febrile response
resulting from intradermal injection of rabbits with eitherLung collection and virus titration
RPV or RPVDB5R, whereas, the data of Table 1 compares
Mice were sacrificed by cervical dislocation. Lungs overt clinical symptoms.
were removed, weighed, and stored at 0707C until fur- Rabbits infected with wild-type RPV (Fig. 1A) showed
ther processing. Lungs were thawed, the tissue was dis- a sharp increase in body temperature (pyrexia) beginning
rupted in 2.0 ml of sterile PBS using a Stomacher lab approximately 2 days postinoculation and persisting until
blender 80 (Tekmar Co., Cincinnati, OH), and the homog- death or, in the 25 – 50% of the animals which survived,
enate was frozen and thawed twice more. Samples were until approximately 10 days postinoculation. Presumably,
then briefly sonicated before titration. this pyrexia results in part from the fact that RPV, unlike
many orthopoxviruses fails to synthesize a secreted IL-
Construction of RPVDB5R
1b receptor (Alcami and Smith, 1992), which is important
in preventing infection-induced fever (Alcami and Smith,The construction of RPVDB5R, a virus containing a
distruption in the B5R gene has been described else- 1992, 1996).
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TABLE 1
Development of Clinical Symptoms in Rabbits Infected with Two Doses of either RPV or RPVDB5R
Nasal Secondary
Virus and Dose discharge Dyspnea Hemorrhage lesions Fever Death
RPV 50 pfu A 0 0 0 / / /
RPV 50 pfu B / / 0 / / /
RPV 5 1 103 pfu A 0 / 0 / / /
RPV 5 1 103 pfu B / 0 0 / / 0
RPVDB5R 50 pfu A 0 0 0 0 0 0
RPVDB5R 50 pfu B 0 0 0 0 0 0
RPVDB5R 5 1 103 pfu A 0 0 0 0 0 0
RPVDB5R 5 1 103 pfu B 0 0 0 0 0 0
Note. Individual rabbits were inoculated intradermally with 50 or 5 1 103 PFU of either RPV or RPVDB5R and examined each day thereafter as
described in the legend to Fig. 1. Two rabbits (designated A and B) were used for each dose of virus. The chart tabulates individual symptoms
observed during the course of the infection. / Indicates the animal was positive for that symptom while 0 indicates the animal was negative.
All animals infected with wild-type RPV exhibited at also showed that many exhibited a neutrophilic infiltrate
within the dermis. It is noteworthy that many more inflam-least some of the classical signs of illness (Table 1) and
three of the four infected animals failed to survive the matory cells were observed from RPV-generated lesions
than those generated by RPVDB5R. One explanation forinfection. By contrast, rabbits infected with RPVDB5R
(Fig. 1B) showed no significant increase in body tempera- these observations could be a reduced growth of
RPVDB5R within the lesion. We observed similar resultsture at any time during the infection. There was no vire-
mia as evidenced by the complete absence of secondary for animals infected with 5 1 104 PFU of virus (data not
shown).lesions, little if any symptoms of clinical disease, and all
of the animals survived (Table 1).
Animals infected with wild-type RPV developed signifi- Attenuation of RPVDB5R in mice
cant induration at the site of inoculation beginning 2 days
postinoculation, which remained throughout the infec- The extreme sensitivity of rabbits to lethal infection
with RPV, makes the determination of the LD50 for thistion. Secondary lesions, resulting from viremia, were fre-
quently observed by 6 days postinfection. Examination virus impractical. To more accurately quantitate the ex-
tent of RPVDB5R attenuation, the LD50 for this mutantof the RPVDB5R primary lesions indicated that there was
some induration present in these animals at the site of was reexamined in a mouse intranasal infection model
in which weight loss and mortality are used to gauge theinoculation, although the indurated area was much less
significant than that seen in the RPV-infected animals virulence and lethality of the virus (Bloom et al., 1991).
The results of this experiment are illustrated in Fig. 3.(data not shown). Unlike RPV-infected animals, where
the induration increased throughout the experiment, the Mice inoculated with wild-type RPV lost weight in a dose-
dependent manner as expected and death, resulting frominduration generated by RPVDB5R infections began de-
creasing on Day 6 postinoculation and had usually re- the viral infection, occurred in animals infected with
doses greater than 105 PFU yielding an LD50 (Reed andsolved by Day 12.
A histological examination of the primary lesions was Meunch, 1938) of 105.6 PFU (Fig. 3A). In contrast, inocula-
tion of mice with identical doses of RPVDB5R resultedperformed 4 days after infection from RPV and RPVDB5R
animals inoculated with 5 1 102 PFU of virus (Fig. 2). in either minimal or no weight loss (Fig. 3B). No mortality
ever resulted from infection of mice with RPVDB5R, evenThe results indicated that lesions from RPVDB5R-in-
fected animals exhibited no necrosis, no hemorrhage, following inoculation of the animals with doses as high
as 108 PFU (data not shown). The LD50 for RPVDB5R canfew if any inflammatory cells, and basically resembled
those of animals inoculated with PBS (Fig. 2a). This was therefore be estimated to be about a 1000-fold greater
than the LD50 for wild-type RPV (Reed and Meunch, 1938).in sharp contrast to the histological picture of animals
infected with RPV where extensive tissue destruction and This result is in agreement with our earlier results (Marti-
nez Pomares et al., 1993) and with similar studies inhemorrhage was evident (Fig. 2b). The epidermis of RPV-
infected animals showed severe vacuolization together vaccinia (Engelstad and Smith, 1993).
The observation that RPVDB5R was severely attenu-with necrosis that extended through the dermis and into
the skeletal muscle bundles at the deep border of the ated in mice was consistent with the results obtained
with this mutant in rabbits. To evaluate inflammation andsections. While not particularly evident in Fig. 2b, an ex-
amination of thin sections from RPV-infected animals necrosis, a histological examination of the lungs from
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FIG. 2. Histological examination of primary lesions from infected rabbit skin. PBS (a) or PBS containing 5 1 102 PFU of either RPV (b) or RPVDB5R
(c) was injected intradermally into a single rabbit. A skin sample including the site of inoculation was removed 4 days postinfection, sectioned, and
the sections were stained with hematoxylin and eosin prior to examination. Skin sections are shown at 2001 magnification.
FIG. 4. Lung sections from intranasally infected mice. 20 ml of PBS (A) or PBS containing 104.5 PFU of RPV (B), RPVDB5R (C), or RPVDSPI-2 (D)
was administered intranasally to BALB/c mice. Four days following infection, the lungs were removed, sectioned, and the sections were stained
with hematoxylin and eosin for examination. Sections are shown at 1001 magnification.
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FIG. 7. Histopathology of pocks formed on infected CAMs. The chorioallantoic membrane of 11-day-old chicken embryos were inoculated with
PBS (uninfected), wild-type RPV, or RPVDB5R and incubated as described under Materials and Methods. After 72 hr, the CAMs were removed and
individual pocks were excised, sectioned, and stained with hematoxylin/eosin for analysis. Sections are shown at both 2001 and 4001 magnification.
infected mice were performed 4 days after intranasal Infection with either RPV or RPVDSPI-2 resulted in the
development of periarteriolar, peribronchiolar, and alveo-infection with either PBS, RPV, RPVDB5R, or RPVDSPI-
2. Lungs from RPVDSPI-2(crmA)-infected mice were lar edema. Both RPV- and RPVDSPI-2-infected lungs con-
tained a mixed (neutrophilic and lymphocytic) inflamma-included as a positive control as the presence of the SPI-
2(crmA) protein is believed to supress the host inflamma- tory cell infiltrate; however, the response was consis-
tently more severe in RPVDSPI-2-infected lungs. Intory response. The results are summarized in Fig. 4.
contrast, lungs from RPVDB5R-infected mice showed no
evidence of either edema or necrosis. However, a low
level of mixed inflammatory cell infiltrate, similar to that
observed in the RPV-infected lungs, was noted. The level
of inflammatory cell infiltrate present in these lungs was
somewhat increased in comparison to RPV although it
was not as severe as the infiltration observed in
RPVDSPI-2-infected tissue.
Growth of RPVDB5R in the mouse lung
We and others have previously reported that defects
in the B5R gene of RPV or vaccinia resulted in a cell-
FIG. 3. Weight change in mice following intranasal infection. Mice line-dependent defect in extracellular-enveloped virus
were infected intranasally with 103 (l), 104(j), 105(l), or 106(m) PFU production, resulting in an altered host range (Takahashi
of RPV or RPVDB5R. Eight animals were examined at each dose.
Nishimaki et al., 1991; Engelstad and Smith, 1993; Eng-Weights of the animals were determined daily for up to 10 days follow-
elstad et al., 1992; Isaacs et al., 1992; Wolffe et al., 1993;ing inoculation. At the highest dose of RPV (106 PFU) three animals
failed to survive the infection (D). Martinez Pomares et al., 1993). If a similar host range
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the simple inability to grow could also explain the de-
creased titer of RPVDB5R and the resulting attenuation
of this mutant observed in infected animals. To determine
if the decreased yield of RPVDB5R observed in the lung
was due to an increased host inflammatory response in
the RPVDB5R-infected animal, we measured the amount
of virus produced in the lungs of infected mice under
conditions where the inflammatory response has been
suppressed. Suppression of the inflammatory response
was achieved by treating the mice prior to infection,
twice-daily, with dexamethasone, a known and potent,
anti-inflammatory agent (see Materials and Methods).
Suppression of the inflammatory response in the dexa-
methasone-treated mice was confirmed by measuring
the reduction in phorbol-ester-induced ear swelling (Fig.
6A). The level of virus present in the lungs of control and
FIG. 5. Growth of RPV and RPVDB5R in mouse lung. Mice were
infected intranasally with 106 PFU of either wtRPV (l) or RPVDB5R (s).
At the times indicated, lungs were removed and the amount of virus
present was measured by determination of titers on RK-13 cells. Four
mice were analyzed at each time point.
restriction occurs in the infected animal, then impaired
viral growth alone could explain the severe attenuation
observed. To measure the ability of RPVDB5R to grow
in the animal, within a localized environment, a growth
experiment was performed using the mouse (lung) as a
growth chamber. Mice were infected intranasally with a
lethal dose of virus and the ability of the virus to grow
was measured by monitoring viral titers in the lung at
various times throughout the course of the infection. As
shown in Fig. 5, the titers of virus in the lungs of wild-
type RPV-infected animals rapidly increases to yield a
titer of 108 PFU/lung on Day 5 postinfection. In contrast,
the yield of virus in RPVDB5R-infected animals is consid-
erably (at least 100-fold) lower when compared to the
wild-type RPV group, correlating with the diminished
weight loss and lack of morbidity observed in these ani-
mals. Although the level of RPVDB5R produced is much
less than that of wild-type RPV, comparison of the final
titer of RPVDB5R with that seen at zero time in
RPVDB5R-infected animals shows an overall small but
reproducible increase in titer, demonstrating that the mu-
tant is able to grow, to some extent, in the mouse lung.
Effect of dexamethasone on virus replication in mice FIG. 6. Effect of dexamethasone treatment on subsequent viral yields
in mice. (A) To confirm the anti-inflammatory effects of dexamethasone,
We have previously shown that RPVDB5R produces mice were either untreated (black bar) or treated twice-daily with dexa-
white pocks on the CAM. The white pocks produced by methasone as described under Materials and Methods (gray bar). On
the 4th day of treatment, ear swelling was induced by the applicationRPVDB5R are similar in appearance to those produced
of croton oil to one ear. Ear thickness was measured 4 hr postapplica-by SPI-2 deletion mutants of either RPV and CPV which
tion. (B) Groups of mice, either untreated (open symbols) or dexametha-have been shown to be the result of an enhanced host
sone treated (closed symbols) were infected with 104.5 PFU of RPV (s/
inflammatory response (Palumbo et al., 1989, 1993; Fred- l) or RPVDB5R (n/m). At the specified times, lungs were removed from
rickson et al., 1992). Loss of the ability of the virus to four animals and the amount of virus was measured by determination of
titers on RK-13 cells. Error bars, when significant, are shown.suppress the host inflammatory response, rather than
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TABLE 2dexamethasone-treated, infected animals was deter-
mined, 4, 6, and 8 days postinoculation, by plaque assay. Virus Titers from Lungs of Infected Mice
The results of this experiment are shown in Fig. 6B. The
Day 4 P.I. Day 6 P.I.total amount of virus present in the lungs of infected,
untreated animals was similar to that seen in the previ-
(0)MPA (/)MPA (0)MPA (/)MPAous experiment, with wild-type RPV-infected animals pro-
ducing 2– 3 orders of magnitude more virus than RPV 7.17a 0 7.3 0
RPVDB5R-infected animals. Dexamethasone-induced RPVDB5R 4.52 4.48 4.72 4.72
RPV /suppression of the host inflammatory response did not
RPVDB5R 7.3 4.57 7.5 4.74alter the level of virus seen in either wtRPV- or RPVDB5R-
infected animals at Day 4 following infection although
Note. Mice (four per group) were infected with 104.5 of RPV,
the virus titers appeared to decrease at a slower rate RPVDB5R, or both of these viruses. Lungs were removed at the times
through Day 8 in the dexamethasone-treated mice, per- indicated and the total amount of virus present was quantified by deter-
mination of the titer on CV-1 cells in the absence (0) of mycophenolichaps indicating some inhibition in the clearance of the
acid (MPA). The level of recombinant virus present in each samplevirus.
was estimated by determination of the titer in the presence (/) of MPA.
a The log of the titer is presented.
Measurement of virus growth in mice coinfected with
wtRPV and RPVDB5R
was similar to that seen in animals infected with wtRPV
Although the results from the previous experiment sug- alone. Titering of the samples in the presence of MPA,
gested that the dexamethasone-sensitive steps of the to determine the level of RPVDB5R virus in coinfected
inflammatory response are not responsible for the de- lungs, revealed that coinfection with RPV had no effect
creased viral yields observed in RPVDB5R-infected ani- on RPVDB5R levels. In all cases the level of mutant virus
mals, it remained formally possible that the B5R protein was identical to that seen in the lungs of animals infected
acts on a component of the inflammatory system not with RPVDB5R alone. This result suggests that the B5R
effected by dexamethasone. To address this possibility, protein cannot produce an environment in the lung which
we asked whether the B5R protein present in the mouse leads to enhanced growth of the RPVDB5R mutant.
lung could, in some way, alter the environment of the
lung and allow for increased production of RPVDB5R; in The nature of the white pocks produced by RPVDB5R
other words, could the B5R protein produced by wtRPV
achieve a physiological, localized, environmental com- We have no evidence, based on animal experiments,
to suggest that infection with RPVDB5R leads to an en-plementation of the B5R mutation. This was tested by
infecting mice intranasally with either RPVDB5R, wild- hanced inflammatory response which could account for
the poor growth of this virus. None of the data obtainedtype RPV, or an equal mixture of the two viruses, and
measuring the resulting yields of each virus at 4 and from infected rabbits would suggest that infection with
RPVDB5R leads to enhancement of the host inflamma-6 days following infection. Since the RPVDB5R mutant
contains the gene for the E. coli guanyl-ribosylphospho- tory response. In addition, treatment of mice with dexa-
methasone prior to infection to inhibit the inflammatorytransferase (gpt), the levels of this virus in the coinfected
lung can be distinguished from that of wild-type RPV by response, did not lead to increased growth of RPVDB5R.
These results would seem to contradict our earlier re-performing plaque assays in the presence or absence
of mycophenolic acid. The results of this experiment are sults showing that RPVDB5R produces white pocks on
the CAM, which by analogy with CPVDSPI-2 would beshown in Table 2. Lungs removed from animals infected
with either RPV or RPVDB5R alone contained levels of expected to produce an enhanced inflammatory re-
sponse (Fredrickson et al., 1992; Palumbo et al., 1993,virus similar to those seen in previous experiments at
both 4 and 6 days following infection with either virus 1989; Pickup et al., 1986). If the formation of white pocks
by RPVDB5R is the result of enhanced inflammation, thenalone, when the titers were determined in the absence
of mycophenolic acid. Determination of the level of virus the pocks, like those of CPV or RPVD SPI-2 (crmA) mu-
tants should contain activated heterophils (Fredricksonpresent in the lungs of both of these singly infected
groups in the presence of MPA gave the expected result; et al., 1992).
We therefore performed a histological analysis ofi.e., lung samples from RPV-infected animals produced
no plaques in the presence of MPA, whereas samples CAMs infected with wild-type RPV and RPVDB5R (Fig.
7). Uninfected membranes show no pathology and werefrom RPVDB5R-infected animals produced the same
numbers of plaques in the presence of MPA as seen in free of heterophils. Infection with wild-type RPV results
in a marked proliferation of both the chorionic epithelialthe absence of the drug.
When lung samples from the mixedly infected mice cells and the fibroblast cells of the stroma. The epithe-
lium in the lesion showed ballooning degeneration aswere titered in the absence of MPA, the level of virus
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well as necrosis and exfoliation of the epithelial layer. hibited by dexamethasone, the white pocks produced by
CPVDcrmA mutants phenotypically revert to red pocksA mild heterophilic cell infiltrate was observed in the
epithelium as well as in the stromal layer. Blood vessels (Fredrickson et al., 1992). CAMs were infected with CPV,
RPV, RPVDcrmA, CPVDcrmA, or RPVDB5R in the ab-within the stroma appeared dilated and hemorrhage was
evident. These last features were more easily observed sence or presence of 8 mM dexamethasone and exam-
ined 72 hr after infection (Fig. 9). All mutant pocks wereunder low power magnification of intact pocks (data not
shown). Surprisingly, infection of the CAM with RPVDB5R white in the absence of dexamethasone, whereas RPV
and CPV generate the expected red pocks. In the pres-produces pocks containing many of the same features
as noted for wild-type RPV (Fig. 7), although there were ence of dexamethasone, pocks produced by both
RPVDcrmA and CPVDcrmA pocks were red, consistentseveral noticeable differences. RPVDB5R pocks, like
those of RPV were also defined by extensive proliferation with a dexamethasone-mediated inhibition of inflamma-
tion. However, dexamethasone had no effect on the whiteof the epithelial and stromal layers. The epithelium
showed similar ballooning degeneration, necrosis, and pocks produced by RPVDB5R. The resulting pocks re-
mained white and appeared similar to those produced inexfoliation as noted for RPV. However, the degree of
exfoliation was less severe in the RPVDB5R pocks. Un- the absence of the drug. Therefore, despite the increased
presence of heterophils in the lesions of RPVDB5Rlike the RPV pocks, the pocks generated by RPVDB5R
appear to contain large numbers of heterophils, most of pocks, there is no other indication that this represents a
typical inflammatory response.which were contained within the stromal layer. In addi-
tion, the innervating blood vessels of the RPVDB5R le-
sions were not dilated and there was a noticeable lack DISCUSSION
of hemorrhage within these pocks in comparison to the
pocks generated by wild-type RPV. Many of the membrane-associated poxvirus proteins
found in the extracellular enveloped virus particle (EEV)The presence of heterophils in the lesions on the CAM
produced by RPVDB5R is surprising in view of our results have been studied to gain a better understanding of their
contribution to infection and the morphogenesis of thein infected animals and would suggest that the white
pocks produced by the B5R mutant are inflammatory and virus (Schmutz et al., 1991; Blasco and Moss, 1991, 1992;
Blasco et al., 1993; McIntosh and Smith, 1996; Parkinsontherefore quite similar to those produced by CrmA (SPI-
2) mutants of CPV (Palumbo et al., 1989). A simple but et al., 1995; Engelstad and Smith, 1993; Duncan and
Smith, 1992; Engelstad et al., 1992; Payne, 1992, 1980;indirect test for the presence of activated heterophils
involves the staining of the pocks with nitroblue tetrazo- Payne and Kristensson, 1982). A common feature shared
by many of these proteins is that deletion of the relevantlium (NBT), which is reduced to formazan by free-oxygen
radicals produced by the activated heterophils within in- ORF often interrupts the terminal steps of viral morpho-
genesis, resulting in inhibition in the formation of EEV,flammatory lesions. Production of formazan is indicated
by an intense blue color. Indeed, the assay has been the extracellular form of infectious virus (Blasco and
Moss, 1991; Schmutz et al., 1991; Hirt et al., 1986; Duncanused as an indicator of the presence of activated hetero-
phils within these pocks (Palumbo et al., 1994). and Smith, 1992; Parkinson and Smith, 1994; McIntosh
and Smith, 1996; Rodriguez and Smith, 1990; Blasco andWe have reconfirmed those results and shown that
RPV or CPV mutants defective in the SPI-2 gene (but not Moss, 1992; Isaacs et al., 1992; Gong et al., 1989). Since
it is believed that it is the enveloped form of the viruswild-type virus) produce white pocks on the CAM which
turn dark blue in the presence of NBT. However, the that is responsible for virus spread, both in tissue culture
and in the infected animal (Payne, 1980; Blasco andwhite pocks produced by RPVDB5R do not stain blue
even upon prolonged exposure to NBT (data not shown), Moss, 1992; Payne and Kristensson, 1982) it is not sur-
prising that several of these EEV protein mutants havesuggesting that despite the presence of increased num-
bers of heterophils, these white pocks are of a fundamen- been shown to fail to plaque and/or are attenuated in
vivo (Schmutz et al., 1991; Blasco and Moss, 1991; McIn-tally different nature than those produced by the SPI-2
mutants (Fig. 8). tosh and Smith, 1996). What is particularly interesting
about the B5R ORF in this context, is that deletion of theAnother method of evaluating the white pocks pro-
duced on the CAM is the response of the developing gene confers a host range (Takahashi Nishimaki et al.,
1991; Martinez Pomares et al., 1993; Wolffe et al., 1993;pock to dexamethasone, a commonly used suppressor
of inflammation. If the host inflammatory response is in- Engelstad and Smith, 1993), implying that the protein is
FIG. 8. NBT staining of infected CAMs. CAMs were infected as described under Materials and Methods. The upper panel shows CAMs after
removal from the eggs at 72 hr postinfection. The lower panel shows the same membranes following a 30-min incubation at 377 in PBS containing
0.1% NBT (wv.).
FIG. 9. Effect of dexamethasone on pock color in eggs. The CAMS were infected and the eggs were incubated with the indicated virus resuspended
in either PBS (top panel) or PBS containing 8 mM dexamethasone (lower panel). Membranes were removed and examined 72 hr postinfection.
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essential for EEV formation in some cells and not in of infected animals suggest that despite the ability of
RPVDB5R to grow in certain cells in culture, the dataothers. The B5R protein is also rather unique among the
EEV proteins in that in addition to being a membrane is most consistent with the notion that attenuation of
RPVDB5R mutants in animals is linked to a simple failurecomponent of EEV, the protein is also secreted from the
cell in a morphogenesis-independent manner; i.e., in the to grow and that the inflammatory process is likely not
affected by the B5R gene product. Therefore, we reinves-absence of virion assembly (Martinez Pomares et al.,
1993). The B5R protein has homology to Factor H, a com- tigated the nature of the white pocks produced by
RPVDB5R. The RPVDB5R white pocks, like the whiteponent of the complement cascade (Takahashi Nishi-
maki et al., 1991; Engelstad and Smith, 1993), suggesting pocks produced by crmA mutants have an enhanced
influx of heterophils but unlike the crmA-induced whitethat it might belong to the family of proteins known to be
host response modifiers and might somehow function to pocks failed to reduce NBT to formazan and were not
phenotypically reverted to red pocks by application ofinhibit inflammation. Hence it was not surprising when
it was discovered that a mutant of RPV, lacking the B5R dexamethasone to the infected CAM. These results sug-
gest that the white pocks produced by B5R mutants areORF, produced white pocks on the CAM, similar to those
produced by the well-studied virus mutants in the crmA noninflammatory, and therefore intrinsically different than
those produced by crmA mutants, implying that there isprotein. One known function of the crmA protein is to
inhibit the interleukin-1b convertase (ICE). Virus mutants more than one type of white pock. Preliminary experi-
ments suggest that the RPVDB5R white pocks might in-lacking the crmA (SPI-2) gene allow an influx of inflamma-
tory cells into the lesion which will ultimately develop stead be a consequence of hyperplasia of the CAM at
the site of infection, a feature easily observed under low-into a white pock. We have attempted to address a basic
question in this communication; namely, whether the at- power magnification. It may also be that the failure of
these pocks to turn red is due to a lack of vasodilationtenuation of the RPVDB5R mutant in vivo is the result
of an enhanced inflammatory response which serves to and/or vascular damage within the pock, which may re-
sult from an impaired production of virus.better contain the infection or simply a consequence of
failure of the RPVDB5R mutant to effectively grow or
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